Pohl-Boskamp

Founded: 1835 • Age: 191 yrs
Pharmaceutical drugs are developed by Pohl-Boskamp in the healthcare sector.
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Pohl-Boskamp

Pohl-Boskamp is a company founded in 1835. Pohl-Boskamp has completed 2 acquisitions, including Kalmeda and MyNoise. Pohl-Boskamp offers products and services including ELOM-080 and Kalmeda Tinnitus-App.

  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name G. Pohl-Boskamp Gmbh & Co. Kg
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $1.04 M (USD), Grant

    Jun 03, 2022

  • Investors
  • Employee Count
    Not available
  • Investments & Acquisitions
    Kalmeda

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Pohl-Boskamp

Pohl-Boskamp offers a comprehensive portfolio of products and services, including ELOM-080 and Kalmeda Tinnitus-App.

Product name locked
Category locked
Primary

This medicine is used for treating respiratory conditions and was evaluated in clinical trials

Product name locked
Category locked
Locked

This app is utilized for managing tinnitus and has been secured through company acquisitions

Funding Insights of Pohl-Boskamp

Investors in Pohl-Boskamp

Pohl-Boskamp has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for Pohl-Boskamp

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Pohl-Boskamp

Pohl-Boskamp has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Kalmeda and MyNoise.

Investments
Premium access

Investment portfolio details for Pohl-Boskamp

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
App for tinnitus management
Locked Locked 2015 Locked
Mobile app providing cognitive behavioral therapy for chronic Tinnitus management.
Locked Locked 2013 Locked
Premium access

Complete acquisition details for Pohl-Boskamp

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Pohl-Boskamp

Premium access

Detailed financials for Pohl-Boskamp

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Pohl-Boskamp Comparisons

Pohl-Boskamp Primary company
Description
Pharmaceutical drugs are developed by Pohl-Boskamp in the he...
Location
-
Founded Year
1835
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Pohl-Boskamp

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Pohl-Boskamp

Premium access

Detailed competitors of Pohl-Boskamp

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Pohl-Boskamp

Premium access

Complete news archive for Pohl-Boskamp

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pohl-Boskamp

Pohl-Boskamp was founded in 1835 and raised its 1st funding round 186 years after it was founded.

Pohl-Boskamp was established in 1835 as a pharmaceutical entity focused on drug development. Operations are centered on creating and manufacturing medicinal products for various therapeutic areas. The company is headquartered in Germany, where research and production activities are conducted. Services include formulation and distribution of pharmaceuticals, supporting healthcare needs across domestic and international markets. No specific location details beyond the national base are provided.

Pohl-Boskamp offers ELOM-080 and Kalmeda Tinnitus-App.

Pohl-Boskamp has made 2 acquisitions, including Kalmeda, and MyNoise.

Pohl-Boskamp has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available